Zobrazeno 1 - 10
of 737
pro vyhledávání: '"Canil, C."'
Autor:
Sawaya GB; Faculty of Medicine and Health Sciences, Department of Surgery, McGill University, Montréal, QC, Canada., Dragomir A; Faculté de Pharmacie, Université de Montréal, Montréal, QC, Canada. Electronic address: alice.dragomir@umontreal.ca., Wood LA; Queen Elizabeth II Health Sciences Center, Dalhousie University, Halifax, NS, Canada., Kollmannsberger C; British Columbia Cancer Care, Vancouver, BC, Canada., Basappa NS; Alberta Health Services, Edmonton, AB, Canada., Kapoor A; Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada., Soulières D; Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada., Finelli A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Heng DYC; University of Calgary, Calgary, AB, Canada., Castonguay V; Centre Hospitalier Universitaire de Québec, Université Laval, Québec, QC, Canada., Canil C; The Ottawa Hospital Research Institute, Ottawa, ON, Canada., Winquist E; Department of Oncology, Western University and London Health Sciences Centre, London, ON, Canada., Graham J; Univeristy of Manitoba, Winnipeg, MB, Canada., Bjarnason GA; Sunnybrook Odette Cancer Centre, Toronto, ON, Canada., Bhindi B; University of Calgary, Calgary, AB, Canada., Lalani AK; Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada., Pouliot F; Centre Hospitalier Universitaire de Québec, Université Laval, Québec, QC, Canada., Breau RH; The Ottawa Hospital Research Institute, Ottawa, ON, Canada., Saleh R; McGill University Health Centre, Montréal, QC, Canada., Tanguay S; McGill University Health Centre, Montréal, QC, Canada.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Jun; Vol. 7 (3), pp. 570-580. Date of Electronic Publication: 2023 Dec 13.
Autor:
Chi KN; BC Cancer-Vancouver Centre and Vancouver Prostate Centre; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Canil C; Division of Medical Oncology, The Ottawa Hospital Cancer Centre and The Ottawa Hospital Research Institute, University of Ottawa; Ottawa, ON, Canada., Alimohamed N; Division of Medical Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Soulières D; CHUM; Faculty of Medicine, Université de Montréal, Montreal, QC, Canada., Breau RH; Division of Urology, Department of Surgery and Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Publikováno v:
Canadian Urological Association journal = Journal de l'Association des urologues du Canada [Can Urol Assoc J] 2024 Jan; Vol. 18 (1), pp. E46-E52.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Background: Survival outcomes are poor for patients with metastatic urothelial carcinoma who receive standard, first-line, platinum-based chemotherapy. We assessed the overall survival of patients who received durvalumab (a PD-L1 inhibitor), with or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::4ed876eb504d06506c168e1bee83f448
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3120446
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3120446
Autor:
Flannigan R; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Prostate Cancer Supportive Care Program, Vancouver Prostate Centre, Vancouver, BC, Canada., Matthew A; Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Sparanese S; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Prostate Cancer Supportive Care Program, Vancouver Prostate Centre, Vancouver, BC, Canada., Wu E; Prostate Cancer Supportive Care Program, Vancouver Prostate Centre, Vancouver, BC, Canada., Guirguis S; Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Sundar M; Prostate Cancer Supportive Care Program, Vancouver Prostate Centre, Vancouver, BC, Canada., Saad F; Department of Surgery, Division of Urology, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, QC, Canada., Loblaw A; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada., Nargi J; Department of Physical Therapy, University of Toronto, Toronto, ON, Canada., Witherspoon L; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Prostate Cancer Supportive Care Program, Vancouver Prostate Centre, Vancouver, BC, Canada., Canil C; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and the University of Ottawa, Ottawa, ON, Canada., Rendon RA; Department of Urology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada., Labelle L; Division of Psychosocial Oncology, Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.; Supportive Care Lead, South Cancer Care Alberta, Alberta Health Services, AB, Canada., Turner J; Supportive Care Lead, North Cancer Care Alberta, Alberta Health Services, AB, Canada.; Division of Palliative Medicine, Department of Oncology, University of Alberta, Edmonton, AB, Canada., Higano C; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Prostate Cancer Supportive Care Program, Vancouver Prostate Centre, Vancouver, BC, Canada.
Publikováno v:
Canadian Urological Association journal = Journal de l'Association des urologues du Canada [Can Urol Assoc J] 2023 Feb; Vol. 17 (2), pp. 61-63.
Autor:
Mahler M; Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Al-Ezzi E; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Shrem NS; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada., Zhang L; Division of Medical Oncology and Hematology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Winquist E; Department of Oncology, University of Western Ontario and London Health Sciences Centre, London, Ontario, Canada., Canil C; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada., Ong M; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada., Hansen AR; Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Division of Medical Oncology, Princess Alexandra Hospital, Brisbane, Australia., Emmenegger U; Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. Electronic address: urban.emmenegger@sunnybrook.ca.
Publikováno v:
Urologic oncology [Urol Oncol] 2022 Dec; Vol. 40 (12), pp. 539.e17-539.e22. Date of Electronic Publication: 2022 Oct 20.
Autor:
Dragomir A; McGill University, Montreal, Canada. Electronic address: alice.dragomir@mcgill.ca., Nazha S; McGill University, Montreal, Canada., Tanguay S; McGill University, Montreal, Canada., Breau RH; The Ottawa Hospital, Ottawa, Canada., Bhindi B; Southern Alberta Institute of Urology, Alberta, Canada., Rendon RA; Queen Elizabeth II Health Sciences Centre, Halifax, Canada., Kapoor A; Juravinski Cancer Centre, McMaster University, Hamilton, Canada., Hotte SJ; Juravinski Cancer Centre, McMaster University, Hamilton, Canada., Basappa N; Cross Cancer Institute, University of Alberta, Edmonton, Canada., Fairey A; Cross Cancer Institute, University of Alberta, Edmonton, Canada., So AI; British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada., Kollmannsberger C; British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada., Finelli A; Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Canada., Hansen A; Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Canada., Canil C; The Ottawa Hospital, Ottawa, Canada., Heng D; Tom Baker Cancer Centre, University of Calgary, Calgary, Canada., Lattouf JB; Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, Canada., Bjarnason G; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Canada., Power N; Western University, London, Canada., Pouliot F; Centre Hospitalier Universitaire de Québec, University of Laval, Quebec, Canada., Wood LA; Queen Elizabeth II Health Sciences Centre, Halifax, Canada.
Publikováno v:
European urology focus [Eur Urol Focus] 2022 Nov; Vol. 8 (6), pp. 1703-1710. Date of Electronic Publication: 2021 Nov 01.
Autor:
Bou-Nehme Sawaya, G, Dragomir, A, Kollmannsberger, C, Basappa, NS, Kapoor, A, Soulières, D, Finelli, A, Heng, DYC, Wood, L, Castonguay, V, Canil, C, Winquist, E, Graham, J, Bjarnason, GA, Bhindi, B, Lalani, AK, Pouliot, F, Breau, RH, Tanguay, S
Publikováno v:
In Value in Health December 2022 25(12) Supplement:S39-S39
Autor:
Shrem NS; Division of Medical Oncology, Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada., Wood L; Division of Medical Oncology, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada., Hamilton RJ; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada., Kuhathaas K; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada., Czaykowski P; Department of Medical Oncology and Hematology, CancerCare Manitoba, University of Manitoba, Winnipeg, MB, Canada., Roberts M; Division of Urology, Department of Surgery, University of Ottawa, Ottawa, ON, Canada., Matthew A; Department of Surgical Oncology, Princess Margaret Cancer Centre, Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Izard JP; Departments of Urology and Oncology, Queen's University, Kingston, ON, Canada., Chung P; Department of Radiation Oncology, Radiation Medicine Program, Princess Margaret Hospital, University of Health Network, University of Toronto, Toronto, ON, Canada., Nappi L; Division of Medical Oncology, British Columbia Cancer - Vancouver Cancer Centre, University of British Columbia, Vancouver, BC, Canada., Jones J; Department of Supportive Care, Princess Margaret Cancer Centre, Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Soulières D; Division of Medical Oncology/Hematology, Le Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada., Aprikian A; Division of Urology, Department of Surgery, McGill University Health Centre, Montreal, QC, Canada., Power N; Division of Urology, Department of Surgery, Western University, London, ON, Canada., Canil C; Division of Medical Oncology, Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
Publikováno v:
Canadian Urological Association journal = Journal de l'Association des urologues du Canada [Can Urol Assoc J] 2022 Aug; Vol. 16 (8), pp. 257-272.
Autor:
Hamilton RJ; Department of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada., Canil C; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and the University of Ottawa, Ottawa, ON, Canada., Shrem NS; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and the University of Ottawa, Ottawa, ON, Canada., Kuhathaas K; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Jiang MD; Department of Medicine, Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada., Chung P; Department of Radiation Oncology, Radiation Medicine Program, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada., North S; Department of Oncology, Division of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada., Czaykowski P; Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada., Hotte S; Division of Medical Oncology, Juravinski Cancer Centre, Hamilton, ON, Canada., Winquist E; Division of Medical Oncology, Western University and London Health Sciences Centre, London, ON, Canada., Kollmannsberger C; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada., Aprikian A; Division of Urology, Department of Surgery, McGill University Health Centre, Montreal, QC, Canada., Soulières D; Division of Medical Oncology/Hematology, Le Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada., Tyldesley S; Department of Radiation Oncology, University of British Columbia, BC Cancer Vancouver, Vancouver, BC, Canada., So AI; Department of Urologic Sciences, University of British Columbia, BC Cancer Vancouver, Vancouver, BC, Canada., Power N; Division of Urology, Department of Surgery, Western University, London, ON, Canada., Rendon RA; Division of Urology, Department of Surgery, Capital Health - Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada., O'Malley M; Department of Medical Imaging, University Health Network, University of Toronto, Toronto, ON, Canada., Wood L; Division of Medical Oncology, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.
Publikováno v:
Canadian Urological Association journal = Journal de l'Association des urologues du Canada [Can Urol Assoc J] 2022 Jun; Vol. 16 (6), pp. 155-173.